Two pharmaceutical giants, both of which manufacture COVID-19 vaccines, on Tuesday announced shakeups of their executive staffs.

Arpa Garay, the former chief commercial officer of Moderna, has left her role as the

company moves to "increase executive focus" on sales. Angela Hwang, chief commercial officer and global biopharma president of Pfizer, will depart after 27 years with the company. The move comes as Pfizer expects to close its $43 billion deal to buy cancer drugmaker Seagen later this week and plans to create a new oncology division that includes the acquisition early next year.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employee-Paid
Employer-Paid